BioSpace News Archive

First destination therapy that restores natural heart pumping capacity; potential game changer for more than 200,000 untreated severe heart failure patients per year

Akebia’s vadadustat, an investigational oral HIF-PHI, achieves primary efficacy and cardiovascular safety endpoints

Roswell Biotechnologies, Inc., the leader in molecular electronics sensor chips, and imec, a world-leading research and innovation hub in nanoelectronics and digital technologies, announced a partnership to develop the first commercially available molecular electronics biosensor chips.

Rallybio LLC, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders, announced the hiring of Rachael Alford, PhD to lead the Company’s Chemistry, Manufacturing and Controls operations.

ICON plc, a leading global provider of drug and device development and commercialisation services to the pharmaceutical, biotechnology and medical device industries, announced that Dr. Kristen K. Buck has been appointed Chief Medical Officer.

Regeneron Pharmaceuticals, Inc. announced financial results for the first quarter of 2020 and provided a business update..

NovaBay® Pharmaceuticals, Inc. announces the appointment of Andrew D. Jones as Chief Financial Officer and Treasurer, effective May 1, 2020.

TransEnterix, Inc. announced that it plans to release first quarter financial and operating results before the market opens on Thursday, May 14, 2020.

Amicus Therapeutics a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases announced the acceptance of several abstracts for presentation at the American Society of Gene & Cell Therapy 23rd Annual Meeting being held virtually on May 12 – 15.

Anavex Life Sciences Corp. announced that it will issue financial results for its fiscal quarter ended March 31, 2020 on Thursday, May 7th, 2020.